BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8106393)

  • 1. p135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor.
    Colamonici OR; Uyttendaele H; Domanski P; Yan H; Krolewski JJ
    J Biol Chem; 1994 Feb; 269(5):3518-22. PubMed ID: 8106393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.
    Colamonici O; Yan H; Domanski P; Handa R; Smalley D; Mullersman J; Witte M; Krishnan K; Krolewski J
    Mol Cell Biol; 1994 Dec; 14(12):8133-42. PubMed ID: 7526154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction.
    Yan H; Krishnan K; Lim JT; Contillo LG; Krolewski JJ
    Mol Cell Biol; 1996 May; 16(5):2074-82. PubMed ID: 8628273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-alpha/beta and for signal transduction.
    Velazquez L; Mogensen KE; Barbieri G; Fellous M; Uzé G; Pellegrini S
    J Biol Chem; 1995 Feb; 270(7):3327-34. PubMed ID: 7531704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific contribution of Tyk2 JH regions to the binding and the expression of the interferon alpha/beta receptor component IFNAR1.
    Richter MF; Duménil G; Uzé G; Fellous M; Pellegrini S
    J Biol Chem; 1998 Sep; 273(38):24723-9. PubMed ID: 9733772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase.
    Dondi E; Pattyn E; Lutfalla G; Van Ostade X; Uzé G; Pellegrini S; Tavernier J
    J Biol Chem; 2001 Dec; 276(50):47004-12. PubMed ID: 11602573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutant form of p135tyk2, an interferon-alpha inducible tyrosine kinase, suppresses the transformed phenotype of Daudi cells.
    Davis E; Krishnan K; Yan H; Newcomb EW; Krolewski JJ
    Leukemia; 1996 Mar; 10(3):543-51. PubMed ID: 8642873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon alpha (IFN alpha) signaling in cells expressing the variant form of the type I IFN receptor.
    Colamonici OR; Domanski P; Krolewski JJ; Fu XY; Reich NC; Pfeffer LM; Sweet ME; Platanias LC
    J Biol Chem; 1994 Feb; 269(8):5660-5. PubMed ID: 8119902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta.
    Abramovich C; Shulman LM; Ratovitski E; Harroch S; Tovey M; Eid P; Revel M
    EMBO J; 1994 Dec; 13(24):5871-7. PubMed ID: 7813427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein.
    Yan H; Krishnan K; Greenlund AC; Gupta S; Lim JT; Schreiber RD; Schindler CW; Krolewski JJ
    EMBO J; 1996 Mar; 15(5):1064-74. PubMed ID: 8605876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition of the interferon-alpha receptor-binding domain on the TYK2 kinase.
    Yan H; Piazza F; Krishnan K; Pine R; Krolewski JJ
    J Biol Chem; 1998 Feb; 273(7):4046-51. PubMed ID: 9461596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2.
    Platanias LC; Uddin S; Yetter A; Sun XJ; White MF
    J Biol Chem; 1996 Jan; 271(1):278-82. PubMed ID: 8550573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of interferon alpha/beta receptor chain 1 in the structure and transmembrane signaling of the interferon alpha/beta receptor complex.
    Constantinescu SN; Croze E; Wang C; Murti A; Basu L; Mullersman JE; Pfeffer LM
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9602-6. PubMed ID: 7524081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-alpha signaling.
    Yeh TC; Dondi E; Uze G; Pellegrini S
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):8991-6. PubMed ID: 10908660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the protein tyrosine kinase tyk2 by interferon alpha/beta.
    Barbieri G; Velazquez L; Scrobogna M; Fellous M; Pellegrini S
    Eur J Biochem; 1994 Jul; 223(2):427-35. PubMed ID: 8055912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor.
    Gauzzi MC; Barbieri G; Richter MF; Uzé G; Ling L; Fellous M; Pellegrini S
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11839-44. PubMed ID: 9342324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytically active TYK2 is essential for interferon-beta-mediated phosphorylation of STAT3 and interferon-alpha receptor-1 (IFNAR-1) but not for activation of phosphoinositol 3-kinase.
    Rani MR; Leaman DW; Han Y; Leung S; Croze E; Fish EN; Wolfman A; Ransohoff RM
    J Biol Chem; 1999 Nov; 274(45):32507-11. PubMed ID: 10542297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimerization of a chimeric CD4-interferon-alpha receptor reconstitutes the signaling events preceding STAT phosphorylation.
    Krishnan K; Yan H; Lim JT; Krolewski JJ
    Oncogene; 1996 Jul; 13(1):125-33. PubMed ID: 8700538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase.
    Yetter A; Uddin S; Krolewski JJ; Jiao H; Yi T; Platanias LC
    J Biol Chem; 1995 Aug; 270(31):18179-82. PubMed ID: 7629131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the c-cbl proto-oncogene product with the Tyk-2 protein tyrosine kinase.
    Uddin S; Gardziola C; Dangat A; Yi T; Platanias LC
    Biochem Biophys Res Commun; 1996 Aug; 225(3):833-8. PubMed ID: 8780698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.